“We have a difficult time understanding how a company is going to develop a competitive advantage in this space, when at the end of the day they’re producing a commodity, it grows in the ground and you cut it. There’s not really a way to differentiate oneself,” says Del Vicario, in conversation with BNN Bloomberg on Thursday.
“Having said that, there’s obviously clear demand for the product, and our sense is that there are going to be at the end of the day one or two leaders. And if I had to guess, Canopy Growth, being the largest and having some money behind them with Constellation Brands, etc., is probably going to be one of the companies that’s going to emerge from the ashes, if you will, of what we think will at some point be a day of reckoning for these companies,” he says.
Smiths Falls, Ontario’s Canopy Growth continues to wow onlookers with their dealmaking prowess, put on display again last month when the company announced a deal to buy US multi-state operator Acreage Holdings — a US$3.4-billion purchase that stands conditional upon significant movement at the federal level on the legalization of rec cannabis. Canopy followed that up with a move earlier this week which will see the licensed producer buy German medical cannabis research and development company C3 for $343 million.
The action comes as Canopy’s stock price flirts with the $70.00 mark, not seen since the frenzied days leading up to legalization in Canada last October. Altogether, Canopy is now worth a whopping $23 billion in market capitalization.
“They’ve shown an adeptness at consolidating within the industry,” says Del Vicario. “If we had to own a company in the space, this would be it.”
Following the company's fourth quarter results, National Bank Financial analyst Rupert Merer has downgraded Exro Technologies (Exro Technologies Stock Quote,… [Read More]
Following the company's most recent acquisition, Haywood analyst Neal Gilmer has maintained his "Buy" rating on Organigram (Organigram Stock Quote,… [Read More]
RBC analyst Paul Treiber is still not fully convinced that BlackBerry (BlackBerry Stock Quote, Chart, News, Analysts, Financials NYSE:BB) is… [Read More]
HEALWELL AI (HEALWELL AI Stock Quote, Chart, News, Analysts, Financials TSX:AIDX) has made an acquisition that will present the company… [Read More]
TD Cowen analyst Vince Valentini says he is feeling more bullish about Quebecor (Quebecor Stock Quote, Chart, News, Analysts, Financials… [Read More]
Following the company's fourth quarter results, Ventum Capital Markets analysts Andrew Semple has maintained his "Buy" rating on Vext Science… [Read More]